1291138

Sioban B. Keel, M.D. — FEI 3040979316

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 6, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional Details

Clinical Investigator (CI)